Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...

Childhood emotional trauma significantly elevates psoriasis risk by disrupting immune responses, new research reveals. Early ...

Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern ...

Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...

More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

A recent study published in the journal of Egyptian Rheumatology and Rehabilitation revealed that children with psoriasis are ...

Psoriasis Awareness Week is fast approaching beginning on World Psoriasis Day, Wednesday 29th October, and running until ...

FRANKFURT () -Swiss drugmaker Novartis, on a deal-making spree this year, reported a 6% gain in operating income as growth of ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 3 clinical study ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...